Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 7;12(1):5835.
doi: 10.1038/s41598-022-09788-4.

Evaluation of a new transcutaneous bilirubinometer in newborn infants

Affiliations

Evaluation of a new transcutaneous bilirubinometer in newborn infants

Mikael Norman et al. Sci Rep. .

Abstract

To avoid brain damage in newborn infants, effective tools for prevention of excessive neonatal hyperbilirubinemia are needed. The objective of this study was to evaluate a new transcutaneous bilirubinometer (JAISY). For this purpose, 930 bilirubin measurements were performed in 141 newborn infants born near-term or at term (gestational age 35-41 weeks; postnatal age 1-6 days; 71 boys; including 29 infants with darker skin) and compared to those of a previously validated instrument (JM105). In each infant, the mean of three repeated measurements in the forehead was calculated for each instrument, followed by a similar measurement on the chest. The bilirubin values varied between 0 and 320 µmol/l (0-18.8 mg/dl). There was a high degree of agreement with significant correlations between bilirubin values measured with the two devices on the forehead (Pearson's r = 0.94, p < 0.001) and the chest (r = 0.94, p < 0.001). The correlations remained after stratifying the data by gestational age, postnatal age and skin color. The coefficient of variation for repeated bilirubin measurements was 8.8% for JAISY and 8.0% for JM105 (p = 0.79). In conclusion, JAISY provides accurate and reproducible information on low to moderately high bilirubin levels in newborn infants born near-term or at term.

PubMed Disclaimer

Conflict of interest statement

All three authors have shares in Jaisy Health AB, a small start-up innovation company.

Figures

Figure 1
Figure 1
Photograph showing the two devices used in the study (JAISY to the left and JM105 to the right, measuring tape graded in centimeters).
Figure 2
Figure 2
Correlation between t.c. bilirubin values (μmol/L) measured with JM105 and JAISY in the chest (β = 0.92, r = 0.94, p < 0.001) and forehead (β = 0.97, r = 0.94, p < 0.001) of 141 newborn infants (gestational age 35–41 weeks, postnatal age 1–6 days). Filled circles in blue = tester 1 and unfilled circles = tester 2.
Figure 3
Figure 3
Bland–Altman plot with mean ± 2SD for an agreement between JM105 and JAISY measurements of t.c. bilirubin levels (μmol/L) in newborn infants. Unfilled circles = measurements at the chest, filled circles = measurements at the forehead. Mean = JM105 + JAISY/2. Difference = JM105 − JAISY.
Figure 4
Figure 4
Correlation coefficients for t.c. bilirubin values measured with JM105 and JAISY at the forehead and chest, by gestational age. Numbers in each bar indicate the number of infants.
Figure 5
Figure 5
Correlation coefficients for t.c. bilirubin values measured with JM105 and JAISY in the forehead and chest, by postnatal age. Numbers in each bar indicate the number of infants.

Similar articles

Cited by

References

    1. Ebbesen F, et al. Extreme hyperbilirubinaemia in term and near-term infants in Denmark. Acta Paediatr. 2005;94:59–64. doi: 10.1080/08035250410022170. - DOI - PubMed
    1. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004) J. Perinatol. Off. J. Calif. Perinat. Assoc. 2009;29(Suppl 1):S25–45. doi: 10.1038/jp.2008.211. - DOI - PubMed
    1. Kuzniewicz MW, et al. Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns. Pediatrics. 2014;134:504–509. doi: 10.1542/peds.2014-0987. - DOI - PubMed
    1. Slusher TM, et al. Burden of severe neonatal jaundice: A systematic review and meta-analysis. BMJ Paediatr. Open. 2017;1:e000105. doi: 10.1136/bmjpo-2017-000105. - DOI - PMC - PubMed
    1. Alken J, Hakansson S, Ekeus C, Gustafson P, Norman M. Rates of extreme neonatal hyperbilirubinemia and kernicterus in children and adherence to national guidelines for screening, diagnosis, and treatment in Sweden. JAMA Netw. Open. 2019;2:e190858. doi: 10.1001/jamanetworkopen.2019.0858. - DOI - PMC - PubMed

Publication types